Koso Med LLC – Trademark Portfolio

Entity Type: 16

Koso Med LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include KOSO MED, SAVE THE GLOBE, and KOSO SUPER DRINK. The owner is based in Scottsdale, AZ.

6424 E Greenway Pkwy, Ste 100-416

Scottsdale, AZ 85254

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Koso Med LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Koso Med LLC have?

Koso Med LLC has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 2 abandoned.

What trademark classes does Koso Med LLC file in?

Koso Med LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Koso Med LLC's most well-known trademarks?

Koso Med LLC's registered trademark portfolio includes well-known marks such as KOSO MED, SAVE THE GLOBE, and KOSO SUPER DRINK. These are among 3 currently registered trademarks in the portfolio.

What is Koso Med LLC's trademark registration success rate?

Koso Med LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.